Investor
Also: Group K Diagnostics raises $2 million; Online depression intervention benefits high-risk teens.
The new funding, led by Leerink Transformation Partners, brings PatientPop's total backing to $75 million.
In its Q3 2018 earnings call, the company said that diversifying its business model has help stem losses from the declining fitness tracker market.
Six large pharma customers have seen an average of one to two extra prescription fills per patient per year.
Housed on a biochip, the startup's technology can deliver results from a single drop of blood within 15 minutes.
Also: Funding announcements for Think Research, Kinetic and Aura.
The company said its new investment will fuel commercialization of its Pivot program, which consists of an app, a connected carbon monoxide breathalyzer and other resources.
CEO Robbie Cape said the investment will be used to meet demand, build new capabilities and ensure high-quality care.
The collective entity offers its vertically-integrated service to patients in Northern California, and is eyeing platform partnerships elsewhere in the country.
The company plans to use the new money to help speed up its growth and development.